Scarica l'app Stockscreener
6.27
3.69%
-0.24
Pre-mercato:
6.25
-0.02
-0.32%
Precedente Chiudi:
$6.51
Aprire:
$6.55
Volume 24 ore:
317.10K
Relative Volume:
0.01
Capitalizzazione di mercato:
$6.37M
Reddito:
$49,300
Utile/perdita netta:
$-6.27M
Rapporto P/E:
-0.6898
EPS:
-9.09
Flusso di cassa netto:
$-5.38M
1 W Prestazione:
-25.36%
1M Prestazione:
+3,584%
6M Prestazione:
+2,100%
1 anno Prestazione:
+210.40%
Intervallo 1D:
$6.24
$6.98
Intervallo di 1 settimana:
$6.10
$8.77
Portata 52W:
$0.0275
$20.84
Aclarion Inc Stock (ACON) Company Profile
Nome
Aclarion Inc
Settore
Industria
Telefono
833 275 2266
Indirizzo
8181 ARISTA PLACE, BROOMFIELD
Confronta ACON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
6.27 | 6.37M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
239.43 | 38.87B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
74.78 | 12.92B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
58.26 | 10.88B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
64.99 | 10.23B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
112.07 | 9.71B | 1.15B | 96.70M | -161.99M | 1.09 |
Aclarion Inc Borsa (ACON) Ultime notizie
Major Clinical Breakthrough: Leading Medical Center Tests Revolutionary AI-Powered Spine Surgery Technology - StockTitan
Stocks of Aclarion Inc (ACON) are poised to climb above their peers - SETE News
Aclarion secures funding for pivotal CLARITY trial By Investing.com - Investing.com South Africa
Aclarion, Inc. (ACON) Showcases AI-Powered NOCISCAN for Chronic Back Pain Diagnosis at Selby Spine Conference - MSN
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Aclarion Announces CLARITY Trial for Nociscan Now Fully Funded - OrthoSpineNews
12 AI News and Ratings You Should Not Miss - Insider Monkey
Understanding ACON stock ratios for better investment decisions - US Post News
What's Going On With Aclarion Stock Tuesday? - Benzinga
Investor Confidence Grows As Aclarion (ACON) Secures Funding For CLARITY Trial - Stocks Telegraph
Aclarion secures funding for pivotal CLARITY trial - Investing.com
Riding the Waves: A Guide to Investing in ACON Stock - The InvestChronicle
NOCISCAN touted as lumbar pain diagnostic advance - MSN
Aclarion, Inc. Enters into Securities Purchase Agreement for Registered Direct Offering - Defense World
Aclarion’s Retail Following Jumps 60% After Reverse Stock Split As Micro-Cap Health Tech Shares Nearly Double - MSN
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference - OrthoSpineNews
NOCISCAN touted as lumbar pain diagnostic advance By Investing.com - Investing.com UK
Aclarion, Inc. Announces Securities Purchase Agreement - TipRanks
Aclarion announces reverse stock split effective January 29 - MSN
Aclarion announces reverse stock split effective January 29 By Investing.com - Investing.com Australia
Aclarion Announces $4.7 Million Registered Direct Stock Offering - citybuzz -
Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market - Yahoo Finance
Stock market news: Aclarion plunged by 99.50% while Foxx Development surged by 221.11% during mid day trading - Business Upturn
Stock market today: Aclarion -99.69%, CARGO Therapeutics -76.31% among biggest losers in early trading - Business Upturn
Stock market today: Aclarion plunged by 99.72% while Crown Electrokinetics was down by 99.52% in early trading - Business Upturn
Aclarion Takes Bold Step: Executes 1-for-370 Reverse Stock Split to Boost Market Position - The Africa Logistics
Aclarion Announces Updated Product Release That Expands Mri Scanner Access for Nociscan Solution - Marketscreener.com
Aclarion, Inc. Announces First Commercial Agreement in Michigan -August 14, 2024 at 08:08 am EDT - Marketscreener.com
Aclarion, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
Aclarion, Inc. George Frey MD as Key Opinion Leader -January 17, 2023 at 08:29 am EST - Marketscreener.com
Aclarion, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 - Marketscreener.com
Aclarion, Inc. announced that it has received $1 million in funding -September 29, 2024 - Marketscreener.com
Aclarion Launches Surgeon Partnership to Apply Nociscan's Ai Technology to Personal Injury and Workers Compensation Market - Marketscreener.com
Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic Changes - Marketscreener.com
Stock market news: Aclarion plunged by 99.74% while Signing Day Sports surged by 125.77% during mid day trading - Business Upturn
Stock market today: Aclarion declined by 99.74% while Ocean Biomedical surged by 27.94% in early trading - Business Upturn
Aclarion stock plunges to 52-week low, touches $0.03 - MSN
Aclarion announces revised reverse stock split details By Investing.com - Investing.com South Africa
Aclarion stock plunges to 52-week low, touches $0.03 By Investing.com - Investing.com South Africa
Aclarion announces revised reverse stock split details - MSN
Aclarion Announces Revised Split Ratio and Timing for Reverse Stock Split - Yahoo Finance
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Aclarion Inc Azioni (ACON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
8.82%
3.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):